Page 50 - Anseong News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Clusters, rising travel drag on virus battle; new infections over 400 again Posted : 2021-03-09 10:42 Updated : 2021-03-09 14:52 Protesters march from Gyeongbok Palace Station in Seoul's Jongno District toward Cheong Wa Dae on Mar. 8 demanding the South Korean government restitute tuition fees for university students or propose alternative measures for those who couldn't normally attend their post-secondary schools and pay rents for their homes due to COVID-19 risks. Yonhap South Korea's daily new coronavirus cases bounced back to above 400 on Tuesday as continued cluster infections and in...

Fewer N.Koreans Escape During Lockdown

January 29, 2021 A handout photo. Children in protective clothes who have tested positive for Covid-19 at TCS International School in Gwangju are led onto a bus to travel to medical facilities for treatment. Kjdaily.com via South China Morning Post Wearing thick winter coats and sitting close together on the floor, about 20 children without face masks sway back and forth, chanting prayers at the top of their voices. Elsewhere, maskless teenagers dance, jumping up and down and clapping their hands. The scenes broadcast on South Korean television show TCS International School in the southern ci...

Posted : 2021-01-29 21:49 Updated : 2021-01-29 21:49 South Korea's agricultural ministry said Friday it has confirmed another case of highly pathogenic bird flu at an egg farm, with the total confirmed caseload reaching 80. Yonhap South Korea's agricultural ministry said Friday it has confirmed another case of highly pathogenic bird flu at an egg farm, with the total confirmed caseload reaching 80. The latest case of the malign H5N8 strain of avian influenza was reported from Anseong, 77 kilometers south of Seoul, according to the Ministry of Agriculture, Food and Rural Affairs. The farm wa...

Immunoforge's 'PF1801' Is Designated as Orphan Drug by FDA News provided by Share this article Share this article SEOUL, South Korea, Jan. 28, 2021 /PRNewswire/ -- Immunoforge, the company specializing in the development of new drugs for rare musculoskeletal diseases (Representatives: An Seong-Min and Jang Gi-Ho), announced that their new drug candidate PF1801 has been designated as the FDA orphan drug for treatment of the Duchenne muscular dystrophy on January 25. As the orphan drug designation awardee, Immunoforge will be granted the following benefits from the FDA: waiver of qualified clin...